Wholesale Distribution of Pharmaceuticals
We can provide a professional service of:
- Contract Responsible Person (RP) / Deputy RP
- Wholesale Distribution Authorisation – WDA Application
- Good Distribution Practices (GDP) Compliance
- GAP Analysis and Pre-Inspection Audits
- GDP/ RP Training
- Quality Systems – Build, maintain and the maintenance
- Risk Assessment – Development and mitigation
- Audit Planning – Delivery and Corrective Action
Flexible Training and Workshops
We can offer a wide range of courses presented by professional trainers. Our courses are filled with informative and inter-active workshop content.
Pharmacist and Pharmacies
We can help entrepreneurs gain their own pharmacy by aiding with:
- NHS Contract Application
- GPhC Registration
- Standard Operating Procedures (SOP)
- Recruitment
Is your current pharmacy business at risk? We can consult you on:
- Scoping gaps in the local pharmacy services provision?
- “SWOT” analysis, bespoke marketing plan
- Essential Services Support
- GPhC Inspection preparation
- Automation and Optimisation
- Business Development
Care Quality Commission
We can be your ‘one stop shop’ for CQC Registration and Compliance. We can help with the following:
- CQC registration
- Documentation
- Quality Management Systems
- Pre Audit Analysis
- Risk Profiling and Compliance
- Bespoke Consultancy
- Business improvement
- Training and practical implementation
Latest News
MHRA Guidance Note 6
MHRA Guidance Note 6 – Notes for applicants and holders of a Wholesale Dealer’s Licence (WDA(H)) or Broker Registration was updated in November 2022 with some significant changes regarding Brexit.
Patient Complaints against GP Pharmacists increase by 48% in one year
2253 patient complaints were made against pharmacists working in GP practices in the year ending March 2022 compared to 1521 the previous year. This, according to figures recently published by NHS Digital.
Unlicensed Cannabis-Based Products for Medicinal (CBPM) Use
On the 16th of November 2022 the Medicines and Healthcare products Regulatory Agency (MHRA) released a blog with guidance on the process for approving Manufacturing Authorisations/ API Registrations in relation to unlicensed Cannabis-Based Products for Medicinal (CBPM) use.